Terms: = Liver cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Staging
10 results:
1. Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.
Miao C; He X; Chen G; Kahlert UD; Yao C; Shi W; Su D; Hu L; Zhang Z
Aging (Albany NY); 2023 Dec; 15(24):15050-15063. PubMed ID: 38097352
[TBL] [Abstract] [Full Text] [Related]
2. Neuroblastoma: Essential genetic pathways and current therapeutic options.
Salemi F; Alam W; Hassani MS; Hashemi SZ; Jafari AA; Mirmoeeni SMS; Arbab M; Mortazavizadeh SMR; Khan H
Eur J Pharmacol; 2022 Jul; 926():175030. PubMed ID: 35605657
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
Taggart DR; London WB; Schmidt ML; DuBois SG; Monclair TF; Nakagawara A; De Bernardi B; Ambros PF; Pearson AD; Cohn SL; Matthay KK
J Clin Oncol; 2011 Nov; 29(33):4358-64. PubMed ID: 21969516
[TBL] [Abstract] [Full Text] [Related]
4. Bilateral adrenal neuroblastoma is different.
Pederiva F; Andres A; Sastre A; Alves J; Martinez L; Tovar JA
Eur J Pediatr Surg; 2007 Dec; 17(6):393-6. PubMed ID: 18072022
[TBL] [Abstract] [Full Text] [Related]
5. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's cancer Group study.
Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
[TBL] [Abstract] [Full Text] [Related]
6. Risk-based management: current concepts of treating malignant solid tumors of childhood.
Grosfeld JL
J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
[TBL] [Abstract] [Full Text] [Related]
7. [Neuroblastoma in children under than 1 year of age].
Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
[TBL] [Abstract] [Full Text] [Related]
8. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Ambros P; Ambros I; Ladanyi M; Eddy J; Bonilla MA; Gerald W
Eur J Cancer; 1997 Oct; 33(12):2117-20. PubMed ID: 9516865
[TBL] [Abstract] [Full Text] [Related]
9. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, n-myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract] [Full Text] [Related]
10. [Neuroblastoma IV-S. A multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
Rollán Villamarín V; García Aroca J; Costa Borrás E; Cuadros García J; Jiménez Alvarez C; Martínez-Caro A; Martínez Ibáñez V; Mulet Ferragut F; Obiols Arderius P; Pérez La Fuente G
Cir Pediatr; 1994 Oct; 7(4):167-70. PubMed ID: 7865360
[TBL] [Abstract] [Full Text] [Related]
